Fulcrum Therapeutics (FULC) Stock Plummets 55% on Clinical Hold News

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

FULC stock is falling fast today due to a regulatory issue, but Fulcrum Therapeutics remains committed to combating sickle cell disease.

The post Fulcrum Therapeutics (FULC) Stock Plummets 55% on Clinical Hold News appeared first on InvestorPlace.

• Buy This $5 Stock BEFORE This Apple Project Goes Live
• The Best $1 Investment You Can Make Today
• It doesn’t matter if you have $500 or $5 million. Do this now.
• Massive Bear Market “Divergence Event” Ahead… And The #1 Way to Play It